Filing Details
- Accession Number:
- 0001636050-21-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-24 19:21:43
- Reporting Period:
- 2021-03-23
- Accepted Time:
- 2021-03-24 19:21:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1636050 | Sio Gene Therapies Inc. | SIOX | Pharmaceutical Preparations (2834) | 853863315 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1731741 | Pavan Cheruvu | C/O Sio Gene Therapies Inc. 130 West 42Nd Street, 26Th Floor New York NY 10036 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-23 | 100,000 | $2.48 | 180,426 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.50 per share, inclusive. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchase at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
